4//SEC Filing
GEMAYEL GEORGES 4
Accession 0001104659-24-027583
CIK 0001356576other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:03 PM ET
Size
8.4 KB
Accession
0001104659-24-027583
Insider Transaction Report
Form 4
GEMAYEL GEORGES
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2024-02-22+8,252→ 8,252 totalExercise: $27.94Exp: 2034-02-22→ Common Stock (8,252 underlying) - Award
Restricted Stock Units
2024-02-22+5,369→ 5,369 total→ Common Stock (5,369 underlying)
Holdings
- 13,315
Common Stock
Footnotes (3)
- [F1]The option vests on February 22, 2025.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001256088
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:03 PM ET
- Size
- 8.4 KB